TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

News

Brief news reports on Tuberculosis

Wellcome and the Gates Foundation to fund late-stage development of a TB vaccine candidate

Wellcome and the Bill & Melinda Gates Foundation announce US$550 million funding to advance a TB vaccine candidate, M72/AS01E, through a Phase III clinical trial that could be the first in 100 years if proven effective.

Read More →

WHO publishes information notes on the use of bedaquiline and delamanid in children and adolescents with drug-resistant TB

The information notes complement the updated WHO guidelines and operational handbook on the management of TB in children and adolescents released in 2022.

Read More →

WHO call for expressions of interest: Experts to conduct systematic reviews of the evidence on TB and undernutrition

27 June 2023 | Geneva: WHO's Global Tuberculosis Programme has initiated a process to review the evidence on TB and nutrition to update the previous WHO guidelines: Nutritional care and support for patients with tuberculosis.

Read More →

Beyond expectations: study finds treatment success gap in drug-resistant TB

In a recent study published in the Journal of Infection, researchers performed a systematic literature review of global treatment outcomes of extensively drug-resistant Tuberculosis.

Read More →

IJTLD July 2023 issue now online

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

Read More →

TB prevention in England 2021

The UK Health Security Agency released a report presenting people with TB disease notified to the enhanced surveillance scheme in England and aiming to describe the epidemiology of TB in England up to the end of 2021. It is the sixth in a series of 7 reports that will describe different aspects of TB incidence, treatment and prevention in England.

Read More →

Novel device holds promise for diagnosing TB in the 'missing millions'

According to the World Health Organization, each year there are approximately three million undiagnosed cases of tuberculosis (TB) globally, which are characterized as the "missing millions." In a cutting-edge study, scientists have tested a diagnostic device using dielectrophoresis that holds promise for improving TB detection and treatment of patients in high-endemic, under-resourced areas. Bringing diagnostics to the patients who need it most will help meet global targets to reduce the burden of TB. The research results appear in The Journal of Molecular Diagnostics.

Read More →

Proteomics reveals potential targets for drug-resistant TB

TOPLINE:

Down-regulation of plasma exosome-derived apolipoproteins APOA1, APOB, and APOC1 indicates DR-TB status and lipid metabolism regulation in pathogenesis. 

Read More →

Adopting an equitable, person-centered strategy to eliminate TB in a post-COVID-19 era

The following is a summary of “Ending tuberculosis in a post-COVID-19 world: a person-centred, equity-oriented approach,” published in the February 2023 issue of Infectious Diseases by Ryckman, et al.

Read More →

South Africa: Why is the Northern Cape missing its TB targets?

In March this year, the director-general of the Northern Cape government, Justice Bekebeke during a parliamentary oversight visit acknowledged that about 80% of the health facilities in the province did not meet their TB performance targets of finding TB cases and ensuring successful (completed) treatment.

Read More →

Page 48 of 895 · Total posts: 10

←First 47 48 49 Last→